Literature DB >> 23825762

Responsiveness to leukotriene D4 and methacholine for predicting efficacy of montelukast in asthma.

Wei-Jie Guan1, Jin-Ping Zheng, Yi Gao, Cai-Yu Jiang, Yan-Qing Xie, Xu Shi, Zheng Zhu, Jia-Ying An, Xin-Xin Yu, Wen-Ting Liu, Nan-Shan Zhong.   

Abstract

A lower responsiveness to leukotriene D4 (LTD4) or higher LTD4/[methacholine (MCh)] potency ratio might suggest preferable outcomes of short-term montelukast monotherapy in terms of airway inflammation and lung function in asthmatic patients.

Entities:  

Keywords:  Asthma; leukotriene D4 (LTD4); leukotriene-responsive; leukotriene-unresponsive; methacholine (MCh); montelukast

Year:  2013        PMID： 23825762      PMCID： PMC3698267          DOI： 10.3978/j.issn.2072-1439.2013.02.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  8 in total

1.  Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

2.  Leukotriene D4 bronchial provocation test: methodology and diagnostic value.

Authors:  Weijie Guan; Jinping Zheng; Yi Gao; Caiyu Jiang; Jiaying An; Xinxin Yu; Wenting Liu
Journal:  Curr Med Res Opin       Date:  2012-05-03       Impact factor: 2.580

3.  Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.

Authors:  Nathan Rabinovitch; Nora J Graber; Vernon M Chinchilli; Christine A Sorkness; Robert S Zeiger; Robert C Strunk; Leonard B Bacharier; Fernando D Martinez; Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

4.  Correlation between cysteinyl leukotriene release from leukocytes and clinical response to a leukotriene inhibitor.

Authors:  Takeshi Terashima; Kazuhisa Amakawa; Akiko Matsumaru; Kazuhiro Yamaguchi
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes.

Authors:  Weijie Guan; Jinping Zheng; Yi Gao; Caiyu Jiang; Yanqing Xie; Jiaying An; Xinxin Yu; Wenting Liu; Nanshan Zhong
Journal:  J Allergy Clin Immunol       Date:  2012-10-04       Impact factor: 10.793

6.  A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.

Authors:  A Athavale; G A D Souza; R Avasthi; N P Singh; M Kale; A Taneja; K Sireesha
Journal:  J Indian Med Assoc       Date:  2004-02

7.  Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).

Authors:  Masato Suzuki; Masahiko Kato; Hirokazu Kimura; Toru Fujiu; Akihiro Morikawa
Journal:  J Asthma       Date:  2003-06       Impact factor: 2.515

Review 8.  Leukotrienes as mediators of airway obstruction.

Authors:  J M Drazen
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405
  8 in total
  2 in total

1.  Response--dose ratio is a surrogate of cumulative provocative dosage for bronchial provocation tests in asthma.

Authors:  Wei-Jie Guan; Jin-Ping Zheng; Xu Shi; Yan-Qing Xie; Cai-Yu Jiang; Yi Gao; Zheng Zhu; Jia-Ying An; Xin-Xin Yu; Wen-Ting Liu
Journal:  Lung       Date:  2014-06-24       Impact factor: 2.584

2.  Cyclophilin A Plays Potential Roles in a Rat Model of Asthma and Suppression of Immune Response.

Authors:  Cai-Tao Chen; Chun-Xiao Shan; Jun Ran; Lei-Miao Yin; Hai-Yan Li; Yu Wang; Yu-Dong Xu; Jing-Lei Guo; Yang-Lin Shi; Yan-Jiao Chen; Yong-Qing Yang
Journal:  J Asthma Allergy       Date:  2021-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.